Two authoritative obesity experts debate whether the benefit of anti-obesity drugs outweigh their potential medical risks. Bray argues that even modest drug induced weight loss reduces obesity complications (hypertension, coronary disease, diabetes), while Hirsch argues for a moratorium until drugs can be better targeted to specific causes of obesity yet to be defined. To see a full text version of this article, please
click here to view the PDF.
Journal
American Journal of Clinical Nutrition